{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:11:20Z","timestamp":1753891880721,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>It is crucial to explore ways to increase the sensitivity of hepatocellular carcinoma cells to sorafenib.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The HepG2 and Huh7 cell lines with overexpressed HIF-2\u03b1 were constructed. The cells were treated with Xuanfu Hua Tang (Xuanfu HT) containing serum and sorafenib separately and by using both of them, the cell viability and other cell biology functions were detected by CCK-8 and other assays. The mechanism of quercetin was investigated by thermal stability assay and dual luciferase reporter gene assay, and the effects of Xuanfu HT on the transcript and protein levels of Notch1 pathway genes were evaluated by qPCR and Western Blot. The effects of Xuanfu HT in tumor growth was investigates by mice subcutaneous tumor implantation model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The Xuanfu HT increased sensitivity of HepG2 and Huh7 cell lines with overexpressed HIF-2\u03b1to sorafenib, and enhanced inhibition of cell proliferation, migration, invasion and angiogenesis by sorafenib. The component quercetin of Xuanfu HT containing serum could inhibit the binding between HIF-2\u03b1 and the promoter of the transcription factor FOXP3 to inhibit the expression of FOXP3, so as to inhibit the activation of Notch1 pathway and angiogenesis. The expression of FOXP3 counteracted the decrease in Notch1 and VEGF expression, and angiogenic capacity induced by the combined treatment with Xuanfu HT and sorafenib. The tumor growth inhibitory effects of Xuanfu HT and sorafenib in mice were proved by constructing a subcutaneous tumor model.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Xuanfu HT can increase sorafenib sensitivity of hepatocellular carcinoma cells by antagonizing the Notch1 pathway through quercetin-binding HIF-2\u03b1.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1552480","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:28:29Z","timestamp":1747286909000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Study on the mechanism by which Xuanfu Hua Tang increases sensitivity of hepatocellular carcinoma cells to sorafenib by antagonizing the Notch1 pathway through HIF-2\u03b1"],"prefix":"10.3389","volume":"15","author":[{"given":"Wenzhao","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiwan","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglin","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol Oct"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19274","article-title":"Hepatocellular carcinoma in 2021: an exhaustive update","volume":"13","author":"Philips","year":"2021","journal-title":"Cureus"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12980","article-title":"Tspan5 promotes epithelial-mesenchymal transition and tumour metastasis of hepatocellular carcinoma by activating Notch signalling","volume":"15","author":"Xie","year":"2021","journal-title":"Mol Oncol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0159-1","article-title":"Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors","volume":"50","author":"Mendez-Blanco","year":"2018","journal-title":"Exp Mol Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.3390\/cancers11121984","article-title":"Stabilization of hypoxia-inducible factors and BNIP3 promoter methylation contribute to acquired sorafenib resistance in human hepatocarcinoma cells","volume":"11","author":"Mendez-Blanco","year":"2019","journal-title":"Cancers (Basel)"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1758835919855228","DOI":"10.1177\/1758835919855228","article-title":"EGFR-AS1\/HIF2A regulates the expression of FOXP3 to impact the cancer stemness of smoking-related non-small cell lung cancer","volume":"11","author":"Qi","year":"2019","journal-title":"Ther Adv Med Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202003-0601OC","article-title":"Perinatal hypoxia-inducible factor stabilization preserves lung alveolar and vascular growth in experimental bronchopulmonary dysplasia","volume":"202","author":"Hirsch","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"B8","first-page":"3","article-title":"Discussion on clinical application of Xuancoverhua Decoction","volume":"49","author":"Song","year":"2018","journal-title":"Jiangxi J Traditional Chin Med"},{"key":"B9","first-page":"3","article-title":"Study on the antitumor effect of convolvulin in vitro","volume":"33","author":"Haiqing","year":"2011","journal-title":"Hebei Med J"},{"key":"B10","article-title":"Madder anthraquinone induces apoptosis in hepatocellular carcinoma SMMC-7721 cells and its molecular mechanism","volume":"6","author":"Yanshuang","year":"2010","journal-title":"China Journal of Chinese Materia Medica"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2016.08.034","article-title":"Hepatoprotective effect of quercetin: From chemistry to medicine","volume":"108","author":"Miltonprabu","year":"2017","journal-title":"Food Chem Toxicol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/foods9030374","article-title":"The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin","volume":"9","author":"Batiha","year":"2020","journal-title":"Foods"},{"key":"B13","doi-asserted-by":"publisher","first-page":"116933","DOI":"10.1016\/j.lfs.2019.116933","article-title":"Beyond its antioxidant properties: Quercetin targets multiple signalling pathways in hepatocellular carcinoma in rats","volume":"236","author":"Salama","year":"2019","journal-title":"Life Sci"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.3390\/nu11122875","article-title":"Antitumor effects of quercetin in hepatocarcinoma in vitro and in vivo models: A systematic review","volume":"11","author":"Fernandez-Palanca","year":"2019","journal-title":"Nutrients"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3725","article-title":"Sequence\u2212dependent effect of sorafenib in combination with natural phenolic compounds on hepatic cancer cells and the possible mechanism of action","volume":"42","author":"Bahman","year":"2018","journal-title":"Int J Mol Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"8082","DOI":"10.3390\/molecules27228082","article-title":"Effects of sorafenib and quercetin alone or in combination in treating hepatocellular carcinoma: in vitro and in vivo approaches","volume":"27","author":"Abdu","year":"2022","journal-title":"Molecules"},{"key":"B17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.3390\/molecules27228082","article-title":"Quercetin reverses sorafenib-resistant SK-Hep-1 cells to sorafenib by up-regulation of p53 pathway","author":"Huang","year":"2018","journal-title":"FASEB J"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-013-1179-2","article-title":"miR-124 radiosensitizes human glioma cells by targeting CDK4","volume":"114","author":"Deng","year":"2013","journal-title":"J Neurooncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270677","article-title":"Inhibitory effect of lingonberry extract on HepG2 cell proliferation, apoptosis, migration, and invasion","volume":"17","author":"Zhu","year":"2022","journal-title":"PloS One"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2013.09.003","article-title":"Role of sorafenib in overcoming resistance of chemotherapy-failure castration-resistant prostate cancer","volume":"12","author":"Meyer","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.22159\/ijap.2019.v11s6.33576","article-title":"Quercetin improves the efficacy of sorafenib in triple negative breast cancer cells through the modulation of drug efflux transporters expressions","volume":"11","author":"Louisa","year":"2019","journal-title":"Int J Appl Pharmaceutics"},{"key":"B22","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s12640-013-9452-x","article-title":"Quercetin and sorafenib as a novel and effective couple in programmed cell death induction in human gliomas","volume":"26","author":"Jakubowicz-Gil","year":"2014","journal-title":"Neurotox Res"},{"key":"B23","article-title":"Research progress in the treatment of primary liver cancer by traditional Chinese medicine","volume":"20","author":"Yupei","year":"2018","journal-title":"J Liaoning Univ Traditional Chin Med"},{"key":"B24","first-page":"1","article-title":"Review on the treatment of esophageal cancer by traditional Chinese medicine","volume":"2","author":"Yuling","year":"2020","journal-title":"J Oncol Chin Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.v35.9","article-title":"Quercetin as a protective agent for liver diseases: A comprehensive descriptive review of the molecular mechanism","volume":"35","author":"Zhao","year":"2021","journal-title":"Phytother Res"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag0339","article-title":"Antagonism of EGFR and Notch limits resistance to EGFR inhibitors and radiation by decreasing tumor-initiating cell frequency","volume":"9","author":"Hu","year":"2017","journal-title":"Sci Transl Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1552480\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:28:30Z","timestamp":1747286910000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1552480\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,15]]},"references-count":28,"alternative-id":["10.3389\/fonc.2025.1552480"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1552480","relation":{},"ISSN":["2234-943X"],"issn-type":[{"type":"electronic","value":"2234-943X"}],"subject":[],"published":{"date-parts":[[2025,5,15]]},"article-number":"1552480"}}